Skip to content

Author

V. Bittner

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 6938: Body Mass Index, LDL-Cholesterol Response, and Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome

Introduction: Obesity and overweight characterize many patients with acute coronary syndrome (ACS). In the ODYSSEY OUTCOMES trial, alirocumab reduced major adverse cardiovascular events (MACE) post-ACS compared with placebo, with protocol-driven dose up-titration from 75 to 150 mg to achieve target LDL-cholesterol (...

G. Schwartz, H. Tavori, Xin Zheng et al. · 0 citations
Nov 2026

Abstract 10036: Apolipoproteins and Cardiovascular-Kidney-Metabolic-Biomarkers Each Add to Prediction of Residual Cardiovascular Disease Risk After Acute Coronary Syndrome: Insights from the ODYSSEY OUTCOMES Trial

The conclusion that residual risk in ACS is multidimensional is supported, and comprehensive biomarker profiling with a multiplex apolipoprotein panel including apoE phenotypes and emerging CKM tests each provides clinically meaningful improvement in the prediction of MACE and death beyond conventional demographics, di...

N. V. van Neer, J. Jukema, L. Ruhaak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.